65 -- Therapeutics to Treat Neutropenia and Thrombocytopenia Associated with the Acute Radiation Syndrome (ARS)

The contract pertains to the development of therapeutics aimed at treating neutropenia and thrombocytopenia associated with Acute Radiation Syndrome (ARS). Initial steps involved a Request for Information (RFI) issued on October 19, 2004, with an ongoing analysis of the submitted responses. Following this, a draft Request for Proposals (RFP) was expected to be released by July 2005 to solicit industry feedback on ARS-related treatments. The Pre-Solicitation Notice, under Solicitation No. DHHS-ORDC-DDA-05-12, was officially posted on November 18, 2005, with all subsequent updates to be referenced under this solicitation number. The contract focuses on the therapeutic sector within the NAICS code 325414, reflecting pharmaceutical preparations. The contracting officer responsible for this procurement is Darrick A. Early, who can be contacted via email or phone as provided. The notice clarifies that no response to the initial RFI notice is required. While specific details about the agency or exact place of performance are not provided, interested parties are directed to follow the solicitation number for future information and updates.